Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 228Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/09/11/3148505/0/en/Amneal-Receives-U-S-FDA-Approval-of-Sodium-Oxybate-Oral-Solution.html

GLOBENEWSWIRE
11 Sep 2025

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203631

FDA
10 Sep 2025

https://www.globenewswire.com/news-release/2025/09/05/3145233/0/en/Avadel-Pharmaceuticals-to-Present-New-Data-on-LUMRYZ-sodium-oxybate-for-Extended-Release-Oral-Suspension-at-World-Sleep-2025.html

GLOBENEWSWIRE
05 Sep 2025

https://www.globenewswire.com/news-release/2025/06/30/3107346/0/en/Avadel-Pharmaceuticals-Announces-Unanimous-Appeals-Court-Decision-Upholding-FDA-Approval-of-LUMRYZ-in-Narcolepsy-in-Administrative-Procedure-Act-Litigation.html

GLOBENEWSWIRE
30 Jun 2025

https://www.indianpharmapost.com/policy/ema-starts-review-of-sodium-oxybate-in-alcohol-dependence-17323

INDPHARMAPOST
28 Jun 2025

https://www.globenewswire.com/news-release/2025/06/05/3094267/0/en/Avadel-Pharmaceuticals-Receives-Orphan-Drug-Designation-from-FDA-for-LUMRYZ-sodium-oxybate-for-Extended-Release-Oral-Suspension-for-the-Treatment-of-Idiopathic-Hypersomnia.html

GLOBENEWSWIRE
05 Jun 2025